Exostoses (Osteochondromas) – A Patient‑Friendly Guide
Overview
Exostoses—more commonly called osteochondromas—are benign (non‑cancerous) bony growths that arise on the surface of a bone, usually near the growth plate (the area of developing cartilage in children and adolescents). They consist of a core of normal bone covered by a cartilaginous cap.
- Typical age of presentation: 10–20 years, when the skeleton is still growing.
- Gender distribution: Slight male predominance (≈ 1.5 : 1); however, hereditary forms affect both sexes equally.
- Prevalence: Osteochondromas are the most common solitary bone tumor, accounting for ~30–40 % of all benign bone tumors and ~10–15 % of all bone neoplasms.1
- Hereditary vs. solitary: About 85 % are solitary (single lesion). The remaining 15 % occur as part of hereditary multiple exostoses (HME), an autosomal‑dominant condition caused by mutations in the EXT1 or EXT2 genes.
Symptoms
Many osteochondromas are discovered incidentally on X‑ray or during a routine exam because they cause no symptoms. When symptoms do occur, they relate to the size, location, and effect on surrounding structures.
Common manifestations
- Painless lump: A firm, immobile protuberance under the skin, most often found on the long bones of the arms (humerus, radius) or legs (femur, tibia).
- Visible swelling or deformity: When the growth is large enough to alter the contour of a limb.
- Restricted range of motion: The exostosis may interfere with a nearby joint, limiting flexion or extension.
- Neurovascular irritation: Compression of nerves (e.g., ulnar nerve at the elbow) or blood vessels can cause tingling, numbness, weakness, or diminished pulses.
- Pain: Usually a dull ache triggered by activity, friction against clothing, or after a minor trauma. Sudden increase in pain can signal a complication (see Complications section).
- Fracture through the stalk: A “pseudopathologic fracture” may occur after a low‑impact injury because the stalk of the osteochondroma is thinner than normal bone.
- Growth after skeletal maturity: New growth of the cartilaginous cap after age 18 is abnormal and raises concern for malignant transformation.
Causes and Risk Factors
Osteochondromas develop when a fragment of the growth plate (physis) herniates outward and continues to grow in parallel with the parent bone.
Primary causes
- Spontaneous (solitary) lesions: The exact trigger is unknown, but it is thought to involve a localized error in endochondral ossification during childhood.
- Hereditary Multiple Exostoses (HME): Autosomal‑dominant inheritance of pathogenic variants in EXT1 (chromosome 8) or EXT2 (chromosome 11). These genes encode glycosyltransferases needed for heparan sulfate synthesis, which regulates cartilage growth.
Risk factors
- Family history of HME (first‑degree relative with multiple exostoses).
- Male sex (higher incidence of solitary lesions).
- History of skeletal trauma that may disturb the growth plate, although causality is not firmly established.
Diagnosis
Diagnosis combines a clinical exam with imaging studies. The goal is to confirm a benign exostosis, assess size and location, and rule out malignancy.
Clinical assessment
- Inspection and palpation of the lump.
- Evaluation of limb alignment, joint range of motion, and neurovascular status.
Imaging modalities
- Plain radiography (X‑ray): First‑line test. Shows a sessile (broad‑based) or pedunculated (stalk‑like) bony outgrowth continuous with the cortex and medullary canal of the parent bone.
- Computed Tomography (CT): Provides detailed 3‑D anatomy, useful for surgical planning, especially in complex anatomic sites (pelvis, scapula).
- Magnetic Resonance Imaging (MRI): Best for evaluating the thickness of the cartilaginous cap (a cap > 1–2 cm in adults raises suspicion for malignancy) and for detecting soft‑tissue or neurovascular involvement.
- Bone scintigraphy (bone scan): Occasionally used to differentiate active growing lesions from inert ones, particularly in HME patients.
Pathology (rarely needed)
If imaging is equivocal, a core needle biopsy may be performed. Histology shows mature trabecular bone with a hyaline cartilage cap. Absence of atypia helps confirm a benign process.
Treatment Options
Most solitary osteochondromas require no immediate intervention. Treatment decisions are based on symptoms, functional impairment, and risk of complications.
Conservative management
- Observation: Regular follow‑up (clinical exam + X‑ray every 1–2 years) for asymptomatic lesions, especially in children.
- Activity modification: Avoid repetitive pressure or trauma to the area (e.g., protective padding for a protruding shin).
- Pain control: Acetaminophen or NSAIDs (ibuprofen, naproxen) as needed, provided there are no contraindications.
Surgical options
- Excision (resection): Indicated for:
- Persistent pain or functional limitation.
- Neurovascular compression.
- Cosmetic concerns that affect quality of life.
- Suspicion of malignant transformation (large or thickened cartilage cap).
- Deformity correction: For HME patients with multiple lesions causing limb length discrepancy or angular deformities, guided growth (hemiepiphysiodesis) or osteotomy may be performed.
Medications
There are no drugs that shrink existing osteochondromas. Research into targeted therapies for HME (e.g., heparan sulfate mimetics) is ongoing but not yet clinically available.
Post‑operative care
- Weight‑bearing restrictions for 4–6 weeks depending on location.
- Physical therapy to restore range of motion and strength.
- Periodic imaging (usually X‑ray at 3 months) to confirm complete removal.
Living with Exostoses (osteochondromas)
While many people live full, active lives with osteochondromas, some practical steps can reduce discomfort and prevent complications.
Daily management tips
- Protect the lesion: Use cushioned pads or clothing (e.g., knee sleeves) over prominent growths during sports or manual work.
- Maintain healthy weight: Excess body weight increases mechanical stress on weight‑bearing bones, potentially worsening pain.
- Regular self‑checks: Feel for new lumps, changes in size, or increasing firmness, especially during growth spurts.
- Exercise wisely: Low‑impact activities (swimming, cycling) are usually well tolerated; avoid repetitive high‑impact drills that compress the lesion.
- Stay up‑to‑date with follow‑ups: For HME, annual orthopedic review is recommended; for solitary lesions, a visit every 2 years after skeletal maturity is sufficient unless symptoms change.
- Educate caregivers and teachers: Let them know about the lesion to prevent accidental pressure (e.g., during gym class).
Prevention
Because most osteochondromas arise from developmental processes, true primary prevention is limited. However, some measures can lower the risk of complications or limit lesion growth in genetically predisposed individuals.
- Genetic counseling: Families with HME benefit from counseling to understand inheritance patterns and prenatal options.
- Avoidance of direct trauma: While trauma does not cause osteochondromas, it can exacerbate an existing lesion.
- Early detection: Routine pediatric examinations often identify solitary lesions before they become symptomatic.
Complications
Although benign, osteochondromas can lead to serious problems if untreated.
- Mechanical irritation: Friction against skin may cause ulceration or infection.
- Neurovascular compromise: Compression of nerves (e.g., median, ulnar, peroneal) can cause chronic neuropathic pain or motor weakness.
- Fracture: The stalk of a pedunculated exostosis is weaker than normal bone, making it prone to fracture, especially after minor trauma.
- Growth disturbance: Lesions near growth plates can cause angular deformities or limb‑length discrepancies, notably in HME.
- Malignant transformation: Rare (< 1 % of solitary, up to 5 % in HME). Transformation to chondrosarcoma presents with rapid growth, new pain, or a cartilage cap > 2 cm in adults. Immediate imaging and referral are essential.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you experience any of the following:
- Sudden, severe pain at the site of an osteochondroma after a fall or direct blow.
- Rapid swelling, bruising, or deformity suggesting a fracture through the lesion.
- New onset of numbness, tingling, or weakness in the limb that was previously normal.
- Sharp, worsening pain at rest (especially at night) or pain that does not improve with over‑the‑counter pain relievers.
- Fever, redness, or drainage from the skin over the growth, indicating possible infection.
- Signs of systemic illness such as unexplained weight loss, night sweats, or persistent fatigue combined with a growing mass.
References
- Mayo Clinic. Osteochondroma. Updated 2023. https://www.mayoclinic.org
- Cleveland Clinic. Osteochondroma Surgery. 2022. https://my.clevelandclinic.org
- Rizzoli, R. et al. “Management of Hereditary Multiple Exostoses.” Journal of Orthopaedic Research. 2021;39(7):1501‑1512.
- National Institutes of Health (NIH). Genetic and Rare Diseases Information Center. Hereditary Multiple Exostoses. 2022. https://rarediseases.info.nih.gov
- World Health Organization (WHO). Classification of Tumours of Bone. 2020.